Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion type Assertion NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_head.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion evidence source_evidence_literature NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion SIO_000772 14729606 NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion wasDerivedFrom befree-2016 NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion wasGeneratedBy ECO_0000203 NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.